These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7160507)

  • 1. [Glycosaminoglycans in progressive scleroderma].
    Herrmann K; Schinagl A; Gchinagl G; Haustein UF; Lohrisch I
    Dermatol Monatsschr; 1982 Nov; 168(11):761-5. PubMed ID: 7160507
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the modification of serum and urinary mucopolysaccharides of patients with scleroderma using gestagen therapy].
    Holzmann H; Korting GW; Morsches B
    Arch Klin Exp Dermatol; 1968; 231(2):156-60. PubMed ID: 4233426
    [No Abstract]   [Full Text] [Related]  

  • 3. [Urinary glycosaminoglycans in systemic scleroderma].
    Astakhova TA; Balabanova RM
    Ter Arkh; 1980; 52(12):100-5. PubMed ID: 7245055
    [No Abstract]   [Full Text] [Related]  

  • 4. An approach to experimental scleroderma, using urinary glycosaminoglycans from patients with systemic scleroderma.
    Ishikawa H; Suzuki S; Horiuchi R; Sato H
    Acta Derm Venereol; 1975; 55(2):97-107. PubMed ID: 48324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quantitative isolation of acid mucopolysaccharides from urine in progressive scleroderma (author's transl)].
    Kreysel HW; Kraus H; Stuhlsatz HW; Greiling E; Nissen HP; Kimmig J
    Arch Dermatol Res (1975); 1977 Jul; 259(1):11-9. PubMed ID: 143247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A normal urinary excretion of acid mucopolysaccharides in generalized scleroderma.
    Ohlenschlaeger K; Friman C
    Scand J Clin Lab Invest; 1968; 21(4):364-8. PubMed ID: 4236504
    [No Abstract]   [Full Text] [Related]  

  • 7. Scleroderma and urinary excretion of acidic glycosaminoglycans.
    Hardy KH; Rosevear JW; Sams WM; Winkelmann RK
    Mayo Clin Proc; 1971 Feb; 46(2):119-27. PubMed ID: 4251060
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphocyte responsiveness to urinary glycosaminoglycan in systemic scleroderma.
    Ishikawa H; Hattori A
    Dermatologica; 1979; 158(5):328-33. PubMed ID: 312217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scleroderma-inducing glycosaminoglycan in the urine of patients with systemic scleroderma.
    Ishikawa H; Saito Y; Yamakage A; Kitabatake M
    Dermatologica; 1978; 156(4):193-204. PubMed ID: 564296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A contribution to the effects of synthetic progesterone on systemic scleroderma (author's transl)].
    Ishikawa H; Tamura T; Horiuchi R; Tuihiji T; Ishii Y
    Nihon Hifuka Gakkai Zasshi; 1975 Apr; 85(5):299-301. PubMed ID: 125813
    [No Abstract]   [Full Text] [Related]  

  • 11. Failure to demonstrate fibrotic changes in the skin of mice injected with glycosaminoglycan fractions from the urine of scleroderma patients.
    Fox PK; White DD; Cavanagh M; Davies MG; Wusterman F
    Dermatologica; 1982 Feb; 164(2):90-4. PubMed ID: 7075853
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative creatine-creatinine studies in the scope of oral creatine loading in dermatomyositis and progressive scleroderma].
    Kreysel HW
    Hautarzt; 1966 Sep; 17(9):399-406. PubMed ID: 5997316
    [No Abstract]   [Full Text] [Related]  

  • 13. The glycosaminoglycans (mucopolysaccharides) in plasma in patients with renal insufficiency.
    Friman C; Storgårds E; Juvani M; Kock B
    Clin Nephrol; 1977 Oct; 8(4):435-9. PubMed ID: 923162
    [No Abstract]   [Full Text] [Related]  

  • 14. Significant increase of urinary low-sulfated heparan-sulfate-related protein in patients with severe systemic scleroderma.
    Kitabatake M; Ishikawa H; Uchiyama Y
    Dermatologica; 1987; 174(4):166-72. PubMed ID: 3108042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary glycosaminoglycan excretion in systemic sclerosis subsets compared with normal controls.
    Chuck AJ; Murphy J; Weiss JB; Jayson MI
    Br J Rheumatol; 1987 Aug; 26(4):259-61. PubMed ID: 3607377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of acidic glycosaminoglycans (mucopolysaccharides) in urine by an ion exchange method. Application to "collagenoses", gargoylism, the nail-patella syndrome and Farber's disease.
    Wessler E
    Clin Chim Acta; 1967 May; 16(2):235-43. PubMed ID: 4226725
    [No Abstract]   [Full Text] [Related]  

  • 17. [The blood picture in progressive scleroderma].
    Schramm P; Brachtel R
    Z Hautkr; 1976 Dec; 51(24):1025-8. PubMed ID: 1007365
    [No Abstract]   [Full Text] [Related]  

  • 18. [Electrophoretic analysis on polyacrylamide gel of glycosaminoglycans].
    Rivkina VB; Tsimarkina GE; D'iachkova AIa; Kasavina BS; Chukaeva DG
    Lab Delo; 1974; 0(10):597-600. PubMed ID: 4139315
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycosaminoglycans of human serum and their alterations in diabetes mellitus.
    Koźma EM; Olczyk K; Głowacki A; Komosińska K; Sonecki P; Najmiec T; Jaźwiec M
    Acta Biochim Pol; 1996; 43(3):567-74. PubMed ID: 8922042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Electrophoretic analysis of urinary glycosaminoglycans].
    Chukaeva DG; Tsimarkina GE; D'iachkova AIa
    Lab Delo; 1977 Oct; (10):619-22. PubMed ID: 73617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.